Etodolac Tablet, Film Coated
Product Images NDC 68788-8673

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 68788-8673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Etodolac 01)

Chemical structure diagram of Etodolac, the active ingredient in the product. The structure features aromatic and cycloalkane rings with various substituents including a carboxylic acid group.*

FDA Label Image

Etodolac Tablets Usp 400mg (Etodolac 04)

Label for Etodolac Tablets USP 400 mg film-coated tablets by Preferred Pharmaceuticals Inc. The label includes dosage instructions in English and Spanish, manufacturer information listing Taro Pharmaceutical Industries Ltd., storage conditions, and a caution about federal law prohibiting transfer. The label features the product name prominently in a yellow box with black text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.